Tacrolimus and mycophenolate mofetil in clinical liver transplantation: Experience with a steroid-sparing concept

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1415-1416

  Ringe, B ^a   Braun, F ^a   Lorf, T ^a   Canelo, R ^a   Schutz E ^a   Sattler, B ^a   Ramadori, G ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AGED; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DRUG BLOOD LEVEL; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REINFECTION;

EID: 0031832245     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00296-6     Document Type: Conference Paper

References (5)

1. Ringe B, Braun F, Lorf T, et al: Liver Transplant Surg 3:C-71, 1997
2. Braun F, Lorf T, Ringe B: Transplant Int 11:77, 1998
3. Tur-Kaspa R, Laub O: J Hepatol 11:34, 1990
4. Tisone G, Angelico M, Vennarecci G, et al: Liver Transplant Surg 3:C-68, 1997
5. Stegall MD, Wachs ME, Kam I, et al: Liver Transplant Surg 3:C-52, 1997